Will NCT03319667 (Sanofi) still show a study completion date of 30 June 2027 or earlier when checked on 30 July 2027?
deadline 2027-07-30
confidence medium
tier 4 evidence
60%PolySignal estimate
Resolution criterion
Yes if, when NCT03319667 is read on clinicaltrials.gov on 30 July 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 30 June 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 2 October 2026: NCT03319667 is registered as ACTIVE_NOT_RECRUITING, sponsored by Sanofi, with 475 participants. Started 2017-12; announced primary completion 2027-04-05, announced study completion 2027-06-30. Record last updated 2026-05-04. The date under test is 2027-06-30. Source: clinicaltrials.gov/study/NCT03319667
What pushes it up
- The trial is already in 'ACTIVE_NOT_RECRUITING' status, meaning recruitment is complete and recruitment-related delays are eliminated [1].
- The trial has been running since December 2017, suggesting a well-established long-term protocol that is likely running on a fixed schedule [1].
What pushes it down
- Clinical trials frequently experience minor administrative, data-cleaning, or follow-up delays that can easily push the completion date back by a few months [1].
- There is a very narrow window of only one month between the scheduled completion date (30 June 2027) and the evaluation date (30 July 2027), leaving little room for any delay [1].
What would move this number most
Whether Sanofi encounters any minor administrative or data-lock delays in the final months of the trial that prompt them to update the completion date.
How this number is built
| Deadline | 2027-07-30 |
| Base rate | 55% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 45 · 60 · 65 (spread 20 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-02 09:01 |
| Model | gemini-3.5-flash |